Follow-up of patients with refractory or relapsed multiple myeloma after allogeneic hematopoietic cell transplantation
Author:
Affiliation:
1. Department of Medicine II; University Hospital Tübingen; Eberhard Karls University; Tübingen Germany
Publisher
Wiley
Subject
Transplantation
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1111/ctr.12994/fullpdf
Reference29 articles.
1. Prognostic factors in allogeneic transplantation for patients with high-risk multiple myeloma after reduced intensity conditioning;Lee;Exp Hematol,2003
2. Follow-up of patients with progressive multiple myeloma undergoing allografts after reduced-intensity conditioning;Einsele;Br J Haematol,2003
3. Relapse to prior autograft and chronic graft-versus-host disease are the strongest prognostic factors for outcome of melphalan/fludarabine-based dose-reduced allogeneic stem cell transplantation in patients with multiple myeloma;Kroger;Biol Blood Marrow Transplant,2004
4. A clinical staging system for multiple myeloma. Correlation of measured myeloma cell mass with presenting clinical features, response to treatment, and survival;Durie;Cancer,1975
5. International staging system for multiple myeloma;Greipp;J Clin Oncol,2005
Cited by 7 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Efficacy and survival outcome of allogeneic stem-cell transplantation in multiple myeloma: meta-analysis in the recent 10 years;Frontiers in Oncology;2024-07-31
2. Autologous and Allogeneic Stem Cell Transplantation as Salvage Treatment Options for Relapsed/Refractory Multiple Myeloma: A Single-center Experience over 20 Years;Anticancer Research;2022-12
3. Current Role of Allogeneic Stem Cell Transplantation in Multiple Myeloma;Oncology and Therapy;2022-04-04
4. Allogeneic Stem Cell Transplantation in Multiple Myeloma;Cancers;2021-12-23
5. Second allogeneic transplants for multiple myeloma: a report from the EBMT Chronic Malignancies Working Party;Bone Marrow Transplantation;2021-05-11
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3